Panna Sharma - Net Worth and Insider Trading
Panna Sharma Net Worth
The estimated net worth of Panna Sharma is at least $23,433 dollars as of 2024-09-20. Panna Sharma is the CEO of Cancer Genetics Inc and owns about 5,083 shares of Cancer Genetics Inc (CGIX) stock worth over $23,433. Details can be seen in Panna Sharma's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Panna Sharma has not made any transactions after 2016-03-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Panna Sharma
Panna Sharma Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Panna Sharma owns 3 companies in total, including Lantern Pharma Inc (LTRN) , Cancer Genetics Inc (CGIX) , and Vyant Bio Inc (VYNT) .
Click here to see the complete history of Panna Sharma’s form 4 insider trades.
Insider Ownership Summary of Panna Sharma
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LTRN | Lantern Pharma Inc | 2020-06-10 | director & CEO & President |
| CGIX | Cancer Genetics Inc | 2017-02-22 | director & Chief Executive Officer |
| VYNT | Vyant Bio Inc | 2014-05-22 | director & President & CEO |
Panna Sharma Latest Holdings Summary
Panna Sharma currently owns a total of 1 stock. Panna Sharma owns 5,083 shares of Cancer Genetics Inc (CGIX) as of March 17, 2016, with a value of $23,433.
Latest Holdings of Panna Sharma
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGIX | Cancer Genetics Inc | 2016-03-17 | 5,083 | 4.61 | 23,433 |
Holding Weightings of Panna Sharma
Panna Sharma Form 4 Trading Tracker
According to the SEC Form 4 filings, Panna Sharma has made a total of 0 transactions in Cancer Genetics Inc (CGIX) over the past 5 years. The most-recent trade in Cancer Genetics Inc is the acquisition of 50 shares on March 17, 2016, which cost Panna Sharma around $3,885.
Insider Trading History of Panna Sharma
- 1
Panna Sharma Trading Performance
GuruFocus tracks the stock performance after each of Panna Sharma's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Panna Sharma is -19.77%. GuruFocus also compares Panna Sharma's trading performance to market benchmark return within the same time period. The performance of stocks bought by Panna Sharma within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Panna Sharma's insider trading performs compared to the benchmark.
Performance of Panna Sharma
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.27 | | | | | |
| Relative Return to S&P 500(%) | 1.68 | | | | | |
Panna Sharma Ownership Network
Panna Sharma Owned Company Details
What does Lantern Pharma Inc do?
Who are the key executives at Lantern Pharma Inc?
Panna Sharma is the director & CEO & President of Lantern Pharma Inc. Other key executives at Lantern Pharma Inc include 10 percent owner Leslie W. Kreis , 10 percent owner Bios Fund I, Lp , and 10 percent owner Fletcher Aaron G.l. .
Lantern Pharma Inc (LTRN) Insider Trades Summary
Over the past 18 months, Panna Sharma made no insider transaction in Lantern Pharma Inc (LTRN). Other recent insider transactions involving Lantern Pharma Inc (LTRN) include a net sale of 378,237 shares made by Bios Fund I, Lp , and a net sale of 378,237 shares made by Leslie W. Kreis .
In summary, during the past 3 months, insiders sold 0 shares of Lantern Pharma Inc (LTRN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 756,474 shares of Lantern Pharma Inc (LTRN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 756,474 shares.
Lantern Pharma Inc (LTRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lantern Pharma Inc Insider Transactions
Panna Sharma Mailing Address
Above is the net worth, insider trading, and ownership report for Panna Sharma. You might contact Panna Sharma via mailing address: 201 Route 17 North, Rutherford Nj 07070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
